Abstract
In the mid-1970s three groups of pathologists described a lymphomalike disorder associated with systemic symptoms and immunologic abnormalities. Frizzera18 et al. termed the disorder angioimmunoblastic lymphadenopathy (AILD), Lukes and Tindle33 immunoblastic lymphadenopathy and Radaszkiewicz and Lennert46 lymphogranulomatosis X.
Keywords
- Mixed Lymphocyte Culture
- Cold Agglutinin
- Angioimmunoblastic Lymphadenopathy
- Mixed Lymphocyte Culture Reaction
- Bone Marrow Aspiration Smear
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Andrieu JM, Youinou P, Herzog C: Levamisole and autoimmunity in angioimmunoblastic lymphadenopathy. Acta Haematol 62: 117–118, 1979
Asher R, Burgher LW, Feagler JR: Immunoblastic lymphadenopathy presenting as pulmonary interstitial fibrosis. JAMA 237: 2411–2412, 1977
Banik S, Ward RL, Hasleton PS: Immunoblastic lymphadenopathy; Evolution to immunoblastic sarcoma. J Clin Patho132:1101–1120, 1979
Bensa JC, Faure J, Martin H, Sotto JJ, Schaerer R: Levamisole in angioimmunoblastic lymphadenopathy (letter). Lancet 1: 1081, 1976
Bessis M, Brecher G (eds): Hemopoietic Dysplasias (Preleukemic States). New York, Springer, 1977
Bluming AZ, Cohen HG, Saxon A: Angioimmunoblastic lymphadenopathy with dysproteinemia. A pathogenetic link between physiologic lymphoid proliferation and malignant lymphoma. Am J Med 67: 421–428, 1979
Bradley SL, Dines DE, Banks PM, Hill RW: The lung in immunoblastic lymphadenopathy. Chest 80: 312–318, 1981
Brincker H, Birkeland SA: The relationship between disease activity, treatment response, and immunologic reactivity in immunoblastic lymphadenopathy: A longitudinal study of treatment with levamisole and cytostatics. Cancer 47: 266–271, 1981
Budman DR, Koziner B, Cunningham-Rundles C, Filippa D, Good RA: IgA deficiency associated with angioimmunoblastic lymphadenopathy. (Letter) N Engl J Med 298:1204, 1978
Case DC Jr, Clarkson BD, Lee BJ III:Improved survival in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol. Am J Med 63: 897–903, 1977
Cibull ML, Seligson GR, Mouradian JA, Fialk MA, Pasmantier M: Immunoblastic lymphadenopathy and adenocarcinoma of the pancreas. A case report. Cancer 42: 1883–1885, 1978
Cooperberg AA, de Champlain MB, Siminovitch J, Rosenberg A, Schwartz JP: Immunoblastic lymphadenopathy: Case report and literature review. Can Med Assoc J 117:53–57, 1977
Cullen MH, Stansfeld AG, Oliver RTD, Lister TA, Malpas JS: Angio-immunoblastic lymphadenopathy. Report of ten cases and review of the literature. Q J Med 48: 151–177, 1979
Deeg HJ, Singer JW, Huang TW: Angioimmunoblastic lymphadenopathy with retinitis and drug related exacerbations. A clinicopathological case study. Cancer 44: 1745–1750, 1979
Ellegaard J, Boesen AM: Restoration of defective cellular immunity by levamisole in a patient with immunoblastic lymphadenopathy. Scand J Haematol 17: 36–43, 1976
Fisher RI, Jaffe ES, Brayland RC, Andersen JC, Tan HK: Immunoblastic lymphadenopathy. Evolution into a malignant lymphoma with plasmacytoid features. Am J Med 61: 553–559, 1976
Fiorillo A, Pettinato G, Raia V, Mighorati R, Angrisani P, Buffolano W: Angioimmunoblastic lymphadenopathy with dysproteinemia: Report of the first case in childhood evolving toward spontaneous remission. Cancer 48: 1611–1614, 1981
Frizzera G, Moran EM, Rappaport H: Angio-immunoblastic lymphadenopathy with dysproteinaemia. Lancet 1: 1070–1073, 1974
Frizzera G, Moran EM, Rappaport H: Angio-immunoblastic lymphadenopathy. Diagnosis and clinical course. Am J Med 59: 803–817, 1975
Gan E, Van der Weyden MB: Hypercalcaemia and angioimmunoblastic lymphadenopathy. Br Med J 282: 437, 1981
Garam T, Bak M, Bakacs T, Dobrentei E, Petranyi G: Angioimmunoblastic lymphadenopathy: A study of the function of lymphocyte populations. Cancer 47: 2850–2855, 1981
Gleichmann E, Van Elven F, Gleichmann H: Immunoblastic lymphadenopathy, systemic lupus erythematosus and related disorders. Am J Clin Patho172:708–723, 1979
Gusterson BA, Fitzharris BM: Angioimmunoblastic lymphadenopathy with lupus erythematosus cells. Br,J Haematol 43: 149–150, 1979
Hossfeld DK, Hoffken K, Schmidt CG, Diedrichs H: Chromosome abnormalities in angioimmunoblastic lymphadenopathy (letter). Lancet 1: 198, 1976
Howarth CB, Bird CC: Immunoblastic sarcoma arising in a child with immunoblastic lymphadenopathy (letter). Lancet 2: 747–748, 1976
Iseman MD, Schwartz MI, Stanford RE: Interstitial pneumonia in angioimmunoblastic lymphadenopathy with dysproteinemia. A case report with special histopathologic studies. Ann Intern Med 82: 75 2755, 1976
Kalus MJ: Immunoblastic lymphadenopathy. A report of two cases. Arch Pathol Lab Med 100:465–468, 1976
Klajman A, Yaretzky A, Schneider M, Holoshitz Y, Shnear A, Griffel B: Angioimmunoblastic lymphadenopathy with paraproteinemia: A T- and Bcell disorder. Cancer 48: 2433–2437, 1981
Kosmidis PA, Axelrod AR, Palacas C, Stahl M: Angioimmunoblastic lymphadenopathy. A T-cell deficiency. Cancer 42: 447–452, 1978
Kreisler JM, Moreno E, Moneo I Bootello A, Bouza E, Martinez de Letona J, Anaya A: Immunological findings in immunoblastic lymphadenopathy. A detailed case study. Clin Exp Immunnl 27: 497–501, 1977
Krueger GRF, Bergholz M, Bartsch HH, Fischer R, Schauer A: Rubella virus antigen in lymphocytes of patients with angioimmunoblastic lymphadenopathy (AIL). J Cancer Res Clin Oncol 95: 8791, 1979
Libshitz HI, Clouser M, Zornosa J, Osborne BM: Radiographic findings of immunoblastic lymphadenopathy and related immunoblastic proliferations. Am J Roentgenol 129: 875–878, 1975
Lukes RJ, Tindle BH: Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin’s disease. N Engl J Med 292:1–8 1975
Maguire FW, Mills RC, Parker FP: Immulloblastic lymphadenopathy and asbestosis. Cancer 47: 79 1797, 1981
Matz LR, Papadimitriou JM, Carroll JR, Barr AL, Dawkins RL, Jackson JM, Herrmann RP, Armstrong BK: Angioimmunoblastic lymphadenopathy with dysproteinemia. Cancer 40:2152–2160, 1977
Mazur EM, Lovett DH, Enriquez RE, Berg WR, Papac RJ: Angioimmunoblastic lymphadenopathy. Evolution to a Burkitt-like lymphoma. Am J Med 67: 317–324, 1979
Moore SB, Harrison EG, Weiland LH: Angioimmunoblastic lymphadenopathy. Mayo Clin Proc 51: 273–280, 1976
Naparstek Y, Ben-Chetrit E, Okon E, Estrov Z, Eliakim M: Angioimmunoblastic lymphadenopathy in a patient with allergy to insulin: A case report. Cancer 47: 545–547, 1981
Nathwani BN, Rappaport H, Moran EM, Pangalis GA, Kim H: Maliganant lymphoma arising in angioimmunoblastic lymphadenopathy. Cancer 41: 578 - 606, 1978
Neiman RS, Dervan P, Haudenschild C, Jaffe R: Angioimmunoblastic lymphadenopathy. An ultrastructural and immunologic study with review of the literature. Cancer 41: 507–518, 1978
O–Donnell PP, Jiji R, Vigorito R, Price T: Angioimmunoblastic lymphadenopathy. Its association with meningeal involvement. Arch Neurol 37: 598 - 599, 1980
Palutke M, Khilanani P, Weise R: Immunologic and electronmicroscopic characteristics of a case of immunoblastic lymphadenopathy. Am J Clin Pathol 65: 929–941, 1976
Pangalis GA, Moran EM, Rappaport H: Blood and bone marrow in angioimmunoblastic lymphadenopathy. Blood 51: 71–83, 1978
Pope RM, Cederbaum Al, Lewis W, Mannik M: Case report. Immunoblastic lymphadenopathy presenting as respiratory insufficiency. Am J Med Sci 274: 213–219, 1977
Pruzanski W, Sutton DMC, Pantolony D: Angioimmunoblastic lymphadenopathy. An immunochemical study. Clin Immunol Immunopathol 6: 62–76, 1976
Radaszkiewicz T, Lennert K: Lymphogranulomatosis X. Klinisches bild, therapie and prognose. Dtsch Med Wochenschr 100: 1157–1163, 1975
Rudders RA, DeLellis R: Immunoblastic lymphadenopathy. A mixed proliferation of T and B lymphocytes. Am J Clin Pathol 68: 518 - 521, 1977
Salmon SE, Seligmann M: B-cell neoplasia in man. Lancet 2: 1230–1233, 1974
Sampson D, Lui A: The effect of levamisole on cellmediated immunity and suppressor-cell function. Cancer Res 36: 952–955, 1976
Schauer, PK, Straus DJ, Bagley CM, Rudolf RH, McCracken JD, Huff J, Glucksberg H, Bauermeister DE, Clarkson BD: Angioimmunoblastic lymphadenopathy: Clinical spectrum of disease. Cancer 48: 2493–2498, 1981
Schechter SL, Rosenblum D: Immunoblastic lymphadenopathy and hydroxychloroquine (letter). Arthritis Rheum 23: 256–257, 1980
Schultz DR, Yunis AA: Immunoblastic lymphadenopathy with mixed cryoglobulinemia. A detailed case study. N Engl J Med 292: 8 - 12, 1975
Seehafer JR, Goldberg NC, Dicken CH, Su WPD: Cutaneous manifestations of angioimmunoblastic lymphadenopathy. Arch Dermatol 116: 41–45, 1980
Shamoto M, Suchi T: Intracytoplasmic type A virus-like particles in angioimmunoblastic lymphadenopathy. Cancer 44: 1641–1643, 1979
Spector JI, Miller S: Immunoblastic lymphadenopathy. A report of two cases. JAMA 238: 1263–1265, 1977
Symoens J, Rosenthal M: Levamisole in the modulation of the immune response: The current experimental and clinical state. J Reticuloendothel Soc 21: 175–221, 1977
Toth J, Garam T: Immunoblastic lymphadenopathy proceeding to sarcoma (letter). Lancet 1: 102, 1977
Trenchard PM, Whittaker JA, Gough G, Parry H: Rapidly fatal respiratory failure and angioimmunoblastic lymphadenopathy; possible contributions of immunoblastic leukemia, chemotherapy and multiple antibodies directed against mature cells. J Clin Pathol 34: 486–494, 1981
Volk SLR, Monteleone PL, Knight WAK: Chromosomes in AILD (letter). N Engl J Med 292: 975, 1975
Wasser WG, Bockman RS, Alderete M, Alter AA: Immunoblastic lymphadenopathy with hypercalcemia. Mt Sinai J Med 47: 13–16, 1980
Watanabe M: Association of immunoblastic lymphadenopathy and Hashimoto’s thyroiditis. Ann Intern Med 87: 62–64, 1977
Wechsler HL, Stavrides A: Immunoblastic lymphadenopathy with purpura and cryoglobulinemia. Arch Dermatol 113: 636–641, 1977
Weisenburger DD: Immunoblastic lymphadenopathy associated with methyldopa therapy. Cancer 42: 2322–2327, 1978
Weisenburger D, Armitage J, Dick F: Immunoblastic lymphadenopathy with pulmonary infiltrates hypocomplementemia and vasculitis. Am J Med 63: 849–854, 1977
Yataganas X, Papadimitriou C, Pangalis G, Loukopoulos D, Fessas P, Papacharalampous N: Angioimmunoblastic lymphadenopathy terminating as Hodgkin’s disease. Cancer 39: 2183–2189, 1977
Zylak CJ, Banerjee R, Galbraith PA, McCarthy DS: Lung involvement in angioimmunoblastic lymphadenopathy (AIL). Radiology 121: 513–519, 1976
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Stratus, D.J. (1984). Angioimmunoblastic Lymphadenopathy. In: Molander, D.W. (eds) Diseases of the Lymphatic System. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-5198-9_3
Download citation
DOI: https://doi.org/10.1007/978-1-4612-5198-9_3
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-9733-8
Online ISBN: 978-1-4612-5198-9
eBook Packages: Springer Book Archive